Ferring Inc. v. Canada (Health)

Ferring Inc. v. Canada (Health)

The Federal Court of Appeal dismissed the appeals, concluding the Minister's analytical approach to whether generics were required to address listed patents under the NOC Regulations was adequate in these factual circumstances; Ferring did have standing but its application failed on the merits; the standard of...

Source-derived case information.

Citation
2007 FCA 276
Parties
Appellant: Ferring Inc.; Appellant: Sanofi-Aventis Canada Inc.; Respondent: Minister of Health; Respondent: The Attorney General of Canada; Respondent: Apotex Inc.; Respondent: Novopharm Limited
Court
Federal Court of Appeal
Jurisdiction
Canada
Judgment Date
6 September 2007
Procedural Posture
Judicial Review of Minister of Health Decisions Under the Patented Medicines (notice of Compliance) Regulations / Appeal to the Federal Court of Appeal From Federal Court Judgments (judgment Delivered)
Outcome
Appeals dismissed with costs.
Legal Topics
Patented Medicines (notice of Compliance) Regulations, Notices of Compliance, Standing, Standard of Review, Generic Drug Approval
Source Language
en
Administrative Law Patent Law Regulatory Law Pharmaceutical Law Patented Medicines (notice of Compliance) Regulations Notices of Compliance Standing Standard of Review +1 more

Source-derived case record

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Legal principles 3 Authorities cited 5 Party arguments 2
Sign in to unlock

Parties

Ferring Inc.

Appellant

Sanofi-Aventis Canada Inc.

Appellant

Minister of Health

Respondent

The Attorney General of Canada

Respondent

Apotex Inc.

Respondent

Novopharm Limited

Respondent

Procedural Posture

Judicial Review of Minister of Health Decisions Under the Patented Medicines (notice of Compliance) Regulations / Appeal to the Federal Court of Appeal From Federal Court Judgments (judgment Delivered)

  1. 1 Whether the Minister erred in issuing Notices of Compliance without requiring generic manufacturers to address patents added to the register after filing of abbreviated new drug submissions
  2. 2 Whether the innovator (Ferring) had standing to seek judicial review of the Minister's decision
  3. 3 What standard of review applies to Ministerial determinations under the NOC Regulations

Ratio Decidendi

The Federal Court of Appeal dismissed the appeals, concluding the Minister's analytical approach to whether generics were required to address listed patents under the NOC Regulations was adequate in these factual circumstances; Ferring did have standing but its application failed on the merits; the standard of review is correctness for questions of law and patent unreasonableness for questions of fact, with mixed questions generally reviewed for patent unreasonableness unless the legal issue is separable.

Court Disposition

Appeals dismissed with costs.

Orders

  • Appeals dismissed with costs.
  • A copy of these reasons to be filed in Court File Numbers A-161-07, A-162-07 and A-163-07.